ALNY vs LCII · P/E 76, rev $1.29B vs P/E 16, rev $2.06B
Alnylam Pharmaceuticals Inc (ALNY) versus LCI Industries (LCII) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
LCI Industries (LCII) is a recreational vehicles company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported LCII revenue for 2026-06-30 was $2.06B. Net income was $130.1M. Revenue was up 88.8% from 2026-03-31 to 2026-06-30. LCII currently screens at market cap $2.52B and trailing P/E 16.3.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. LCII currently screens at market cap $2.52B and trailing P/E 16.3.
Not investment advice. Open the ALNY and LCII stock pages for the full models.
Not investment advice.